Current through Register Vol. 30, No. 38, September 20, 2024
A. A
medical director shall ensure that a medical evaluation of a patient is
conducted before the patient's abortion is performed that includes:
1. A medical history including:
a. Allergies to medications, antiseptic
solutions, or latex;
b. Obstetrical
and gynecological history;
c. Past
surgeries;
d. Medication the
patient is currently taking; and
e.
Other medical conditions;
2. A physical examination, performed by a
physician that includes a bimanual examination to estimate uterine size and
palpation of adnexa;
3. The
following laboratory tests:
a. A urine or
blood test to determine pregnancy;
b. Rh typing, unless the patient provides
written documentation of blood type acceptable to the physician;
c. Anemia screening; and
d. Other laboratory tests recommended by the
physician or medical director on the basis of the physical examination;
and
4. An ultrasound
imaging study of the fetus, performed as required in A.R.S. §§
36-2156
and
36-2301.02(A).
B. If the medical evaluation
indicates a patient is Rh negative, a medical director shall ensure that:
1. The patient receives information from a
physician on this condition;
2. The
patient is offered RhO(d) immune globulin within 72 hours after the abortion
procedure;
3. If a patient refuses
RhO(d) immune globulin, the patient signs and dates a form acknowledging the
patient's condition and refusing the RhO(d) immune globulin;
4. The form in subsection (B)(3) is
maintained in the patient's medical record; and
5. If a patient refuses RhO(d) immune
globulin or if a patient refuses to sign and date an acknowledgment and refusal
form, the physician documents the patient's refusal in the patient's medical
record.
C. A physician
shall estimate the gestational age of the fetus, based on one of the following
criteria, and record the estimated gestational age in the patient's medical
record:
1. Ultrasound measurements of the
biparietal diameter, length of femur, abdominal circumference, visible
pregnancy sac, or crown-rump length or a combination of these; or
2. The date of the last menstrual period or
the date of fertilization and a bimanual examination of the patient.
D. A medical director shall ensure
that:
1. The ultrasound of a patient required
in subsection (A)(4) is performed by an individual who meets the requirements
in
R9-10-1506(3);
2. An ultrasound estimate of gestational age
of a fetus is performed using methods and tables or charts in a publication
distributed nationally that contains peer-reviewed medical information, such as
medical information derived from a publication describing research in
obstetrics and gynecology or in diagnostic imaging;
3. An original patient ultrasound image is:
a. Interpreted by a physician, and
b. Maintained in the patient's medical record
in either electronic or paper form; and
4. If requested by the patient, the
ultrasound image is reviewed with the patient by a physician, physician
assistant, registered nurse practitioner, or registered nurse.
E. A medical director shall ensure
that before an abortion is performed on a patient:
1. Written consent, that meets the
requirements in A.R.S. §
36-2152
or
36-2153,
as applicable, and A.R.S. §
36-2158
is signed and dated by the patient or the patient's representative;
2. Information is provided to the patient on
the abortion procedure, including alternatives, risks, and potential
complications;
3. Information
specified in A.R.S. §
36-2161(A)(12)
is requested from the patient; and
4. If applicable, information required in
A.R.S. §
36-2161(C)
is provided to the patient.
F. A medical director shall ensure
that an abortion is performed according to the abortion clinic's policies and
procedures and this Article.
G. A
medical director shall ensure that:
1. A
patient care staff member monitors a patient's vital signs throughout an
abortion procedure to ensure the patient's health and safety;
2. Intravenous access is established and
maintained on a patient undergoing an abortion after the first trimester unless
the physician determines that establishing intravenous access is not
appropriate for the particular patient and documents that fact in the patient's
medical record;
3. If an abortion
procedure is performed at or after 20 weeks gestational age, a patient care
staff member qualified in neonatal resuscitation, other than the physician
performing the abortion procedure, is in the room in which the abortion
procedure takes place before the delivery of the fetus; and
4. If a fetus is delivered alive:
a. Resuscitative measures, including the
following, are used to support life:
i.
Warming and drying of the fetus,
ii. Clearing secretions from and positioning
the airway of the fetus,
iii.
Administering oxygen as needed to the fetus, and
iv. Assessing and monitoring the
cardiopulmonary status of the fetus;
b. A determination is made of whether the
fetus is a viable fetus;
c. A
viable fetus is provided treatment to support life;
d. A viable fetus is transferred as required
in
R9-10-1510;
and
e. Resuscitative measures and
the transfer, as applicable, are documented.
H. To ensure a patient's health and safety, a
medical director shall ensure that following the abortion procedure:
1. A patient's vital signs and bleeding are
monitored by:
a. A physician;
b. A physician assistant;
c. A registered nurse practitioner;
d. A nurse; or
e. If a physician is able to provide direct
supervision, as defined in A.R.S. §
32-1401 or
A.R.S. §
32-1800,
as applicable, to a medical assistant, as defined in A.R.S. §
32-1401 or
A.R.S. §
32-1800, a
medical assistant under the direct supervision of the physician; and
2. A patient remains in the
recovery room or recovery area until a physician, physician assistant,
registered nurse practitioner, or nurse examines the patient and determines
that the patient's medical condition is stable and the patient is ready to
leave the recovery room or recovery area.
I. A medical director shall ensure that
follow-up care:
1. For a surgical abortion is
offered to a patient that includes:
a. With a
patient's consent, a telephone call made to the patient to assess the patient's
recovery:
i. By a patient care staff member
other than a surgical assistant; and
ii. Within 24 hours after the patient's
discharge following a surgical abortion; and
b. A follow-up visit scheduled, if requested,
no more than 21 calendar days after the abortion that includes:
i. A physical examination,
ii. A review of all laboratory tests as
required in subsection (A)(3), and
iii. A urine pregnancy test;
2. For a medication
abortion includes a follow-up visit, scheduled between seven and 21 calendar
days after the initial dose of a substance used to induce an abortion, that
includes:
a. A urine pregnancy test,
and
b. An assessment of the degree
of bleeding; and
3. Is
documented in the patient's medical record, including:
a. A patient's acceptance or refusal of a
follow-up visit following a surgical abortion;
b. If applicable, the results of the
follow-up visit; and
c. If
applicable, whether the patient consented to a telephone call and, if so,
whether the patient care staff member making the telephone call to the patient:
i. Spoke with the patient about the patient's
recovery, or
ii. Was unable to
speak with the patient.
J. If a continuing pregnancy is suspected as
a result of the follow-up visit in subsection (I)(1)(b) or (I)(2), a physician
who performs abortions shall be consulted.